AGNIESZKA GLIWA: Open Payments
NPI 1487649919 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$962 in 38 payments from 11 companies in 2025. Trend: 2023 $478 · 2024 $821 · 2025 $962
Food & beverage: $962
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $169 |
| Exact Sciences Corporation | 5 | $151 |
| Astellas Pharma US Inc | 4 | $132 |
| Corcept Therapeutics | 4 | $98 |
| Medtronic, Inc. | 1 | $96 |
| Amneal Pharmaceuticals LLC | 5 | $87 |
| Novo Nordisk Inc | 3 | $70 |
| Dexcom, Inc. | 3 | $64 |
| ABBVIE INC. | 3 | $60 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
Products named: MOUNJARO, Cologuard Collection Kit, Veozah, Korlym, MINIMED 780G, UNITHROID, Wegovy, Dexcom G6 Transmitter.
Industry payments across NY — which companies pay providers there.
